MedPath

Use of Passive, Adaptive, and Active Prosthetic Knees in Persons With Unilateral, Transfemoral Amputation

Not Applicable
Completed
Conditions
Transfemoral Amputation
Interventions
Device: Active knee (Ossur Power Knee II)
Device: Adaptive knee (Ossur Rheo)
Device: Passive knee (Various manufacturers)
Registration Number
NCT02219230
Lead Sponsor
University of Washington
Brief Summary

The goals of this study are to assess measured, observed, and self-reported outcomes achieved through the use of passive (mechanical), active(motorized) and adaptive (magnetorheological) prosthetic knee control systems in individuals with unilateral, transfemoral amputation.

Detailed Description

An interrupted time-series trial with pre/post baseline assessments, randomized crossover of interventions, and within-phase repeated measures is used to evaluate and compare the effectiveness of the Össur Power Knee II and the Össur Rheo Knee in individuals with unilateral, transfemoral amputation. A rigorous and clinically-meaningful experimental protocol is applied to verify study participants receive appropriate training, experience, and assessment in each knee condition. A suite of standardized and ad-hoc physical performance tests, patient-reported questionnaires, and monitoring technologies were carefully selected to assess important, clinically-relevant participant outcomes. Comparative effectiveness of three prosthetic knee interventions are evaluated using direct measurement (i.e., timed tests), observed clinical ratings (i.e., subjective assessments of gait quality) and self-report instruments (i.e., health status surveys). Analyses will focus on identifying differences between control system technologies inherent to each type of prosthetic knee (i.e., passive \[mechanical\], adaptive \[magnetorheological\], and active \[power\]). Outcomes will be used to establish recommendations for which activities and patients knees are most appropriate or likely to produce a desired effect.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria
  • age 45 - 75
  • body weight less than 275lbs
  • unilateral amputation between the hip and knee
  • amputation due to non-vascular causes
  • no other major limb amputations
  • amputation occurred at least 2 years prior
  • stable limb volume (i.e., at least 6 months on an unmodified prosthetic socket)
  • intact skin tissue without open wounds or sores for at least 2 months
  • physiologically stable medical condition (i.e., non-degenerative)
  • possession and regular (i.e., daily) use of a prosthesis with a prosthetic knee with non-microprocessor (i.e., mechanical or fluid) stance control
  • Medicare functional classification level (MFCL or "K-level") 3
Exclusion Criteria
  • expect to receive or are expected to require a replacement prosthetic socket within 15 months
  • complete reliance on an assistive device (i.e., cane or walker) for ambulation

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Prosthetic kneePassive knee (Various manufacturers)Subjects crossed over between interventions (three different prosthetic knees). Knee conditions include 1) Active knee (Ossur Power Knee II); 2) Adaptive knee (Ossur Rheo); and 3) Passive knee (Various manufacturers)
Prosthetic kneeActive knee (Ossur Power Knee II)Subjects crossed over between interventions (three different prosthetic knees). Knee conditions include 1) Active knee (Ossur Power Knee II); 2) Adaptive knee (Ossur Rheo); and 3) Passive knee (Various manufacturers)
Prosthetic kneeAdaptive knee (Ossur Rheo)Subjects crossed over between interventions (three different prosthetic knees). Knee conditions include 1) Active knee (Ossur Power Knee II); 2) Adaptive knee (Ossur Rheo); and 3) Passive knee (Various manufacturers)
Primary Outcome Measures
NameTimeMethod
Timed Stair TestChange from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)

Timed performance test that involves walking up and down 6 steps.

Step activityChange from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)

Average daily step counts measured by an accelerometer-based device.

Obstacle course timeChange from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)

Time to walk a 1/2-mile outdoor walking course.

Timed Up and GoChange from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)

Timed performance test that measures rising from a chair, walking 3m, and returning to a seated position.

Timed Ramp TestChange from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)

Timed performance test that involves walking up and down a 14ft ramp.

Secondary Outcome Measures
NameTimeMethod
Reported FallsChange from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)

Self-report phone survey.

Prosthesis Evaluation Questionnaire (PEQ)Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)

Self-report computerized survey (12 questions)

Activities Specific Balance Confidence Scale (ABC)Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)

Self-report computerized survey (18 questions).

Patient Reported Outcomes Measurement Information System (PROMIS)Change from Baseline (mean score at weeks 1, 2, 3, and 4) to Follow-Up (mean score at weeks 8, 12, 16, 20, 24, and 28)

Self-report computerized questionnaire with 8-14 questions per domain. Includes Physical Function, Fatigue, and General Health subdomains.

Trial Locations

Locations (1)

University of Washington

🇺🇸

Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath